Metastatic melanoma in the older patient: immunologic insights and treatment outcomes

References

• Geller AC, Miller DR, Annas GD et al. Melanoma incidence and mortality among US whites, 1969–1999. JAMA288, 1719–1720 (2002).
   PubMed Web of Science ®Google Scholar
• Balch CM, Gershenwald JE, Soong SJ et al. Final version of 2009 AJCC melanoma staging and classification. J. Clin. Oncol.36, 6199–6206 (2009).
   Google Scholar
• American Cancer Society. Cancer Facts and Figures 2010. American Cancer Society, Atlanta, GA, USA (2010).
   Google Scholar
• Marks R. An overview of skin cancers: incidence and causation. Cancer75, 607–612 (1995).
   PubMed Web of Science ®Google Scholar
• Roush GC, McKay L, Holford TR. A reversal in the long-term increase in death attributable to malignant melanoma. Cancer69, 1714–1720 (1992).
   PubMed Web of Science ®Google Scholar
• Seidler AM, Pennie ML, Veledar E, Culler SD, Chen SC. Economic burden of melanoma in the elderly population. Arch. Dermatol.146, 249–256 (2010).
   PubMedGoogle Scholar
• Cohen HJ, Cox E, Manton K, Woodbury M. Malignant melanoma in the elderly. J. Clin. Oncol.5, 100–106 (1987).
   PubMed Web of Science ®Google Scholar
• Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J. Clin.59, 225–249 (2009).
   Web of Science ®Google Scholar
• Chang CK, Jacobs IA, Vizgirda VM, Salti GI. Melanoma in the elderly patient. Arch. Surg.138, 1135–1138 (2003).
   PubMedGoogle Scholar
• McMasters KM, Noyes RD, Reintgen DS et al. Sunbelt Melanoma Trial. J. Surg. Oncol.86(4), 212–223 (2004).
   PubMed Web of Science ®Google Scholar
• Chao C, Martin RC 2nd, Ross MI et al. Correlation between prognostic factors and increasing age in melanoma. Ann. Surg. Oncol.11, 259–264 (2004).
   PubMed Web of Science ®Google Scholar
• Ortiz CA, Goodwin JS, Freeman JL. The effect of socioeconomic factors on incidence, stage at diagnosis and survival of cutaneous melanoma. Med. Sci. Monit.11, RA163–RA172 (2005).
   PubMed Web of Science ®Google Scholar
• Reyes Ortiz CA, Freeman JL, Kuo YF, Goodwin JS. The influence of marital status on stage at diagnosis and survival of older persons with melanoma. J. Gerontol. A Biol. Sci. Med. Sci.62, 892–898 (2007).
   PubMed Web of Science ®Google Scholar
• Balch CM, Soong SJ, Gershenwald JE et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J. Clin. Oncol.19, 3622–3634 (2001).
   PubMed Web of Science ®Google Scholar
• Lasithiotakis KG, Petrakis LE, Garbe C. Cutaneous melanoma in the elderly: epidemiology, prognosis and treatment. Mel. Res.20, 163–170 (2010).
   PubMed Web of Science ®Google Scholar
• Ershler WB, Stewart JA, Hacker MP, Moore AL, Tindle BH. B16 murine melanoma and aging: slower growth and longer survival in older mice. J. Natl Cancer Inst.72, 161–164 (1984).
   PubMed Web of Science ®Google Scholar
• Hirayama R, Sato K, Hirokawa K et al. Different metastatic modes of malignant melanoma implanted in the ear of young and old mice. Cancer Immunol. Immunother.18, 209–214 (1984).
   PubMed Web of Science ®Google Scholar
• Kaptzan T, Skutelsky E, Itzhaki O et al. Efficacy of anti-angiogenic treatment of tumors in old versus young mice. Mech. Ageing Dev.127, 398–409 (2006).
   PubMed Web of Science ®Google Scholar
• Brand CU, Ellwanger U, Stroebel W et al. Prolonged survival of 2 years or longer for patients with disseminated melanoma. An analysis of related prognostic factors. Cancer79, 2345–2353 (1997).
   PubMed Web of Science ®Google Scholar
• Eton O, Legha SS, Moon TE et al. Prognostic factors for survival of patients treated systemically for disseminated melanoma. J. Clin. Oncol.16, 1103–1111 (1998).
   PubMed Web of Science ®Google Scholar
• Boon T, Coulie PG, Van den Eynde BJ et al. Human T cell responses against melanoma. Ann. Rev. Immunol.24, 1–34 (2006).
   PubMed Web of Science ®Google Scholar
• Mukherji B, Chakraborty NG, Yamasaki S et al. Induction of antigen-specific cytolytic T cells in situ in human melanoma by immunization with synthetic peptide-pulsed autologous antigen presenting cells. Proc. Natl Acad. Sci. USA92, 8078–8082 (1995).
   PubMed Web of Science ®Google Scholar
• Sakaguchi S, Takahashi T, Nishizuka Y. Study on cellular events in post-thymectomy autoimmune oophoritis in mice. II. Requirement of Lyt-1 cells in normal female mice for the prevention of oophoritis. J. Exp. Med.156, 1577–1586 (1982).
   PubMed Web of Science ®Google Scholar
• Chakraborty NG, Li L, Sporn JR et al. Emergence of regulatory CD4+ T cell response to repetitive stimulation with antigen-presenting cells in vitro: implications in designing antigen-presenting cell-based tumor vaccines. J. Immunol.162, 5576–5583 (1999).
   PubMed Web of Science ®Google Scholar
• Rosenberg SA, Restifo NP, Yang JC, Morgan RA, Dudley ME. Adoptive cell transfer: a clinical path to effective cancer immunotherapy. Nat. Rev.8, 299–308 (2008).
   Google Scholar
• Hodi FS, O’Day SJ, McDermott DF et al. Improved survival with ipilimumab in patients with metastatic melanoma. N. Engl. J. Med.363, 711–723 (2010).
   PubMed Web of Science ®Google Scholar
• Pawelec G, Solana R, Remarque E, Mariani E. Impact of aging on innate immunity. J. Leukoc. Biol.64, 703–712 (1998).
   PubMed Web of Science ®Google Scholar
• Aspinall R. Age-related changes in the function of T cells. Micro Res. Tech.62, 508–513 (2003).
   PubMed Web of Science ®Google Scholar
• Grolleau-Julius A, Garg MR, Mo R, Yung RL. Effect of aging on bone marrow-derived murine CD11c+CD4-CD8α- dendritic cell function. J. Gerontol. Biol. Sci.61A, 1039–1047 (2006).
   Google Scholar
• Hegde UP, Chakraborty N, Kerr P, Grant-Kels JM. Melanoma in the elderly patient. Clin. Dermatol.27, 537–544 (2009).
   PubMed Web of Science ®Google Scholar
• Christenson B, Pauksen K, Sylvan PE. Effect of influenza and pneumococcal vaccines in elderly persons in years of low influenza activity. Virol. J.5, 1–9 (2008).
   PubMed Web of Science ®Google Scholar
• Fisman DN, Abrutyn E, Spaude KA, Kim A, Kirchner C, Daley J. Prior pneumococcal vaccination is associated with reduced death, complications, and length of stay among hospitalized adults with community-acquired pneumonia. Clin. Infect. Dis.42, 1093–1101 (2006).
   PubMed Web of Science ®Google Scholar
• Atzpodien J, Wandert T, Reitz M. Age does not impair the efficacy of immunotherapy in patients with metastatic renal cell carcinoma. Crit. Rev. Oncol. Hematol.55, 193–199 (2005).
   PubMed Web of Science ®Google Scholar
• Quan W Jr, Ramirez M, Taylor C et al. Administration of high-dose continuous infusion interleukin-2 to patients age 70 or over. Cancer Biother. Radiopharm.20, 11–15 (2005).
   PubMed Web of Science ®Google Scholar
• Tagawa ST, Cheung E, Banta W, Gee C, Weber JS. Survival analysis after resection of metastatic disease followed by peptide vaccines in patients with stage IV melanoma. Cancer106, 1353–1357 (2006).
   PubMed Web of Science ®Google Scholar
• Ribas A, Camacho LH, Lopez-Berestein G. et al. Anti-tumor activity in melanoma and anti-self responses in a Phase I trial with the anti-cytotoxic T lymphocyte-associated antigen 4 monoclonal antibody CP-675,206. J. Clin. Oncol.23, 8968–8977 (2005).
   PubMed Web of Science ®Google Scholar
• Marshall J, Forester TH, Purdie DM et al. Immunological characteristics correlating with clinical response to immunotherapy in patients with advanced metastatic melanoma. Immunol. Cell Biol.84, 295–302 (2006).
   PubMed Web of Science ®Google Scholar
• Hakim FT, Flomerfelt FA, Boyiadzis M, Gress RE. Aging, immunity and cancer. Curr. Opin. Immunol.16, 151–156 (2004).
   PubMed Web of Science ®Google Scholar
• Tsaknaridis L, Spencer L, Culbertson N et al. Functional assay for human CD4+CD25+ Tregs cells reveals an age-dependent loss of suppressive activity. J. Neurosci. Res.74, 296–308 (2003).
   PubMed Web of Science ®Google Scholar
• Gregg R, Smith CM, Clark FJ et al. The number of human peripheral blood CD4+CD25high regulatory T cells increases with age. Clin. Exp. Immunol.140, 1365–2249 (2005).
   Google Scholar
• Hegde UP, Chhabra A, Chakraborty NG. Lack of Tregs cell function and melanoma tumor antigen-specific responses in some elderly patients. Presented at: 99th Annual Meeting of American Association of Cancer Research. San Diego, CA, USA, 12–16 April 2008.
   Google Scholar